SPIB and BATF provide alternate determinants of IRF4 occupancy in diffuse large B-cell lymphoma linked to disease heterogeneity

Nucleic Acids Research

Volumn 42, Issue 12, 2014, Pages 7591-7610

  Care, Matthew A ^a,b   Cocco, Mario ^a   Laye, Jon P ^a   Barnes, Nicholas ^a   Huang, Yuanxue ^c   Wang, Ming ^c   Barrans, Sharon ^d   Du, Ming ^c   Jack, Andrew ^d   Westhead, David R ^b   Doody, Gina M ^a   Tooze, Reuben M ^a,d  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 4; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88;

ARTICLE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; BATF GENE; CELL TRANSFORMATION; COHORT ANALYSIS; CONTROLLED STUDY; GENE; GENE EXPRESSION PROFILING; GENE MUTATION; GENE SILENCING; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GERMINAL CENTER; GM12878 CELL LINE; HUMAN; HUMAN CELL; IRF4 GENE; LARGE CELL LYMPHOMA; LYMPHOBLASTOID CELL LINE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POPULATION RESEARCH; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; SPIB GENE;

B-LYMPHOCYTES; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; BINDING SITES; CELL DIFFERENTIATION; CELL LINE, TUMOR; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERFERON REGULATORY FACTORS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MUTATION; MYELOID DIFFERENTIATION FACTOR 88; NUCLEOTIDE MOTIFS; PROTO-ONCOGENE PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 84904013438     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku451     Document Type: Article

References (80)

1. Alizadeh, A.A., Eisen, M.B., Davis, R.E., Ma, C., Lossos, I.S., Rosenwald, A., Boldrick, J.C., Sabet, H., Tran, T., Yu, X. et al. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403, 503-511.
2. Shaffer, A.L. 3rd, Young, R.M., Staudt, L.M. (2012) Pathogenesis of human B cell lymphomas. Ann. Rev. Immunol., 30, 565-610.
3. Klein, U., Casola, S., Cattoretti, G., Shen, Q., Lia, M., Mo, T., Ludwig, T., Rajewsky, K., Dalla-Favera, R. (2006) Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat. Immunol., 7, 773-782.
4. Sciammas, R., Shaffer, A.L., Schatz, J.H., Zhao, H., Staudt, L.M., Singh, H. (2006) Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity, 25, 225-236.
5. De Silva, N.S., Simonetti, G., Heise, N., Klein, U. (2012) The diverse roles of IRF4 in late germinal center B-cell differentiation. Immunol. Rev., 247, 73-92.
6. Brass, A.L., Kehrli, E., Eisenbeis, C.F., Storb, U., Singh, H. (1996) Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1. Genes Dev., 10, 2335-2347.
7. Brass, A.L., Zhu, A.Q., Singh, H. (1999) Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers. EMBO J., 18, 977-991.
8. Rao, S., Matsumura, A., Yoon, J., Simon, M.C. (1999) SPI-B activates transcription via a unique proline, serine, and threonine domain and exhibits DNA binding affinity differences from PU.1. J. Biol. Chem., 274, 11115-11124.
9. Escalante, C.R., Brass, A.L., Pongubala, J.M., Shatova, E., Shen, L., Singh, H., Aggarwal, A.K. (2002) Crystal structure of PU.1/IRF-4/DNA ternary complex. Mol. Cell, 10, 1097-1105.
10. Garrett-Sinha, L.A., Su, G.H., Rao, S., Kabak, S., Hao, Z., Clark, M.R., Simon, M.C. (1999) PU.1 and Spi-B are required for normal B cell receptor-mediated signal transduction. Immunity, 10, 399-408.
11. Hu, C.J., Rao, S., Ramirez-Bergeron, D.L., Garrett-Sinha, L.A., Gerondakis, S., Clark, M.R., Simon, M.C. (2001) PU.1/Spi-B regulation of c-rel is essential for mature B cell survival. Immunity, 15, 545-555.
12. DeKoter, R.P., Geadah, M., Khoosal, S., Xu, L.S., Thillainadesan, G., Torchia, J., Chin, S.S., Garrett-Sinha, L.A. (2010) Regulation of follicular B cell differentiation by the related E26 transformation-specific transcription factors PU.1, Spi-B, and Spi-C. J. Immunol., 185, 7374-7384.
13. Schmidlin, H., Diehl, S.A., Nagasawa, M., Scheeren, F.A., Schotte, R., Uittenbogaart, C.H., Spits, H., Blom, B. (2008) Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression. Blood, 112, 1804-1812.
14. Lenz, G., Wright, G.W., Emre, N.C., Kohlhammer, H., Dave, S.S., Davis, R.E., Carty, S., Lam, L.T., Shaffer, A.L., Xiao, W. et al. (2008) Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc. Natl. Acad. Sci. U. S. A., 105, 13520-13525.
15. Lenz, G., Nagel, I., Siebert, R., Roschke, A.V., Sanger, W., Wright, G.W., Dave, S.S., Tan, B., Zhao, H., Rosenwald, A. et al. (2007) Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma. J. Experiment. Med., 204, 633-643.
16. Yang, Y., Shaffer, A.L. 3rd, Emre, N.C., Ceribelli, M., Zhang, M., Wright, G., Xiao, W., Powell, J., Platig, J., Kohlhammer, H. et al. (2012) Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma. Cancer Cell, 21, 723-737.
17. Dorsey, M.J., Tae, H.J., Sollenberger, K.G., Mascarenhas, N.T., Johansen, L.M., Taparowsky, E.J. (1995) B-ATF: a novel human bZIP protein that associates with members of the AP-1 transcription factor family. Oncogene, 11, 2255-2265.
18. Ciofani, M., Madar, A., Galan, C., Sellars, M., Mace, K., Pauli, F., Agarwal, A., Huang, W., Parkurst, C.N., Muratet, M. et al. (2012) A validated regulatory network for th17 cell specification. Cell, 151, 289-303.
19. Glasmacher, E., Agrawal, S., Chang, A.B., Murphy, T.L., Zeng, W., Vander Lugt, B., Khan, A.A., Ciofani, M., Spooner, C.J., Rutz, S. et al. (2012) A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes. Science, 338, 975-980.
20. Li, P., Spolski, R., Liao, W., Wang, L., Murphy, T.L., Murphy, K.M., Leonard, W.J. (2012) BATF-JUN is critical for IRF4-mediated transcription in T cells. Nature, 490, 543-546.
21. Tussiwand, R., Lee, W.L., Murphy, T.L., Mashayekhi, M., Wumesh, K.C., Albring, J.C., Satpathy, A.T., Rotondo, J.A., Edelson, B.T., Kretzer, N.M. et al. (2012) Compensatory dendritic cell development mediated by BATF-IRF interactions. Nature, 490, 502-507.
22. Betz, B.C., Jordan-Williams, K.L., Wang, C., Kang, S.G., Liao, J., Logan, M.R., Kim, C.H., Taparowsky, E.J. (2010) Batf coordinates multiple aspects of B and T cell function required for normal antibody responses. J. Experiment. Med., 207, 933-942.
23. Ise, W., Kohyama, M., Schraml, B.U., Zhang, T., Schwer, B., Basu, U., Alt, F.W., Tang, J., Oltz, E.M., Murphy, T.L. et al. (2011) The transcription factor BATF controls the global regulators of class-switch recombination in both B cells and T cells. Nat. Immunol., 12, 536-543.
24. Care, M.A., Barrans, S., Worrillow, L., Jack, A., Westhead, D.R., Tooze, R.M. (2013) A microarray platform-independent classification tool for cell of origin class allows comparative analysis of gene expression in diffuse large B-cell lymphoma. PLoS ONE, 8, e55895.
25. Doody, G.M., Stephenson, S., Tooze, R.M. (2006) BLIMP-1 is a target of cellular stress and downstream of the unfolded protein response. Eur. J. Immunol., 36, 1572-1582.
26. Doody, G.M., Stephenson, S., McManamy, C., Tooze, R.M. (2007) PRDM1/BLIMP-1 modulates IFN-gamma-dependent control of the MHC class I antigen-processing and peptide-loading pathway. J. Immunol., 179, 7614-7623.
27. Doody, G.M., Care, M.A., Burgoyne, N.J., Bradford, J.R., Bota, M., Bonifer, C., Westhead, D.R., Tooze, R.M. (2010) An extended set of PRDM1/BLIMP1 target genes links binding motif type to dynamic repression. Nucleic Acids Res., 38, 5336-5350.
28. Cocco, M., Stephenson, S., Care, M.A., Newton, D., Barnes, N.A., Davison, A., Rawstron, A., Westhead, D.R., Doody, G.M., Tooze, R.M. (2012) In vitro generation of long-lived human plasma cells. J. Immunol., 189, 5773-5785.
29. Lenz, G., Wright, G., Dave, S.S., Xiao, W., Powell, J., Zhao, H., Xu, W., Tan, B., Goldschmidt, N., Iqbal, J. et al. (2008) Stromal gene signatures in large-B-cell lymphomas. N. Engl. J. Med., 359, 2313-2323.
30. Compagno, M., Lim, W.K., Grunn, A., Nandula, S.V., Brahmachary, M., Shen, Q., Bertoni, F., Ponzoni, M., Scandurra, M., Califano, A. et al. (2009) Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature, 459, 717-721.
31. Williams, P.M., Li, R., Johnson, N.A., Wright, G., Heath, J.D., Gascoyne, R.D. (2010) A novel method of amplification of FFPET-derived RNA enables accurate disease classification with microarrays. J. Mol. Diagn., 12, 680-686.
32. Jima, D.D., Zhang, J., Jacobs, C., Richards, K.L., Dunphy, C.H., Choi, W.W., Au, W.Y., Srivastava, G., Czader, M.B., Rizzieri, D.A. et al. (2010) Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs. Blood, 116, e118-e127.
33. Hummel, M., Bentink, S., Berger, H., Klapper, W., Wessendorf, S., Barth, T.F., Bernd, H.W., Cogliatti, S.B., Dierlamm, J., Feller, A.C. et al. (2006) A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.N. Engl. J. Med., 354, 2419-2430.
34. Monti, S., Savage, K.J., Kutok, J.L., Feuerhake, F., Kurtin, P., Mihm, M., Wu, B., Pasqualucci, L., Neuberg, D., Aguiar, R.C. et al. (2005) Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood, 105, 1851-1861.
35. Salaverria, I., Philipp, C., Oschlies, I., Kohler, C.W., Kreuz, M., Szczepanowski, M., Burkhardt, B., Trautmann, H., Gesk, S., Andrusiewicz, M. et al. (2011) Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults. Blood, 118, 139-147.
36. Monti, S., Chapuy, B., Takeyama, K., Rodig, S.J., Hao, Y., Yeda, K.T., Inguilizian, H., Mermel, C., Currie, T., Dogan, A. et al. (2012) Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma. Cancer Cell, 22, 359-372.
37. Visco, C., Li, Y., Xu-Monette, Z.Y., Miranda, R.N., Green, T.M., Tzankov, A., Wen, W., Liu, W.M., Kahl, B.S., d'Amore, E.S. et al. (2012) Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Leukemia : Off. J. Leukemia Soc. Am., Leukemia Res. Fund, U.K., 26, 2103-2113.
38. Wright, G., Tan, B., Rosenwald, A., Hurt, E.H., Wiestner, A., Staudt, L.M. (2003) A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc. Natl. Acad. Sci. U. S. A., 100, 9991-9996.
39. Langmead, B., Salzberg, S.L. (2012) Fast gapped-read alignment with Bowtie 2. Nat. Methods, 9, 357-359.
40. Guo, Y., Mahony, S., Gifford, D.K. (2012) High resolution genome wide binding event finding and motif discovery reveals transcription factor spatial binding constraints. PLoS Comput. Biol., 8, e1002638.
41. Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y.C., Laslo, P., Cheng, J.X., Murre, C., Singh, H., Glass, C.K. (2010) Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell, 38, 576-589.
42. Kent, W.J., Sugnet, C.W., Furey, T.S., Roskin, K.M., Pringle, T.H., Zahler, A.M., Haussler, D. (2002) The human genome browser at UCSC. Genome Res., 12, 996-1006.
43. Thorvaldsdottir, H., Robinson, J.T., Mesirov, J.P. (2013) Integrative genomics viewer (IGV): high-performance genomics data visualization and exploration. Briefings Bioinformat., 14, 178-192.
44. Rao, S., Garrett-Sinha, L.A., Yoon, J., Simon, M.C. (1999) The Ets factors PU.1 and Spi-B regulate the transcription in vivo of P2Y10, a lymphoid restricted heptahelical receptor. J. Biol. Chem., 274, 34245-34252.
45. Karrich, J.J., Balzarolo, M., Schmidlin, H., Libouban, M., Nagasawa, M., Gentek, R., Kamihira, S., Maeda, T., Amsen, D., Wolkers, M.C. et al. (2012) The transcription factor Spi-B regulates human plasmacytoid dendritic cell survival through direct induction of the antiapoptotic gene BCL2-A1. Blood, 119, 5191-5200.
46. Nguyen, V.T., Benveniste, E.N. (2000) Involvement of STAT-1 and ets family members in interferon-gamma induction of CD40 transcription in microglia/macrophages. J. Biol. Chem., 275, 23674-23684.
47. Himmelmann, A., Riva, A., Wilson, G.L., Lucas, B.P., Thevenin, C., Kehrl, J.H. (1997) PU.1/Pip and basic helix loop helix zipper transcription factors interact with binding sites in the CD20 promoter to help confer lineage- and stage-specific expression of CD20 in B lymphocytes. Blood, 90, 3984-3995.
48. Cisse, B., Caton, M.L., Lehner, M., Maeda, T., Scheu, S., Locksley, R., Holmberg, D., Zweier, C., den Hollander, N.S., Kant, S.G. et al. (2008) Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell, 135, 37-48.
49. Nagasawa, M., Schmidlin, H., Hazekamp, M.G., Schotte, R., Blom, B. (2008) Development of human plasmacytoid dendritic cells depends on the combined action of the basic helix-loop-helix factor E2-2 and the Ets factor Spi-B. Eur. J. Immunol., 38, 2389-2400.
50. Desai, S., Bolick, S.C., Maurin, M., Wright, K.L. (2009) PU.1 regulates positive regulatory domain I-binding factor 1/Blimp-1 transcription in lymphoma cells. J. Immunol., 183, 5778-5787.
51. Ray-Gallet, D., Mao, C., Tavitian, A., Moreau-Gachelin, F. (1995) DNA binding specificities of Spi-1/PU.1 and Spi-B transcription factors and identification of a Spi-1/Spi-B binding site in the c-fes/c-fps promoter. Oncogene, 11, 303-313.
52. Hollenhorst, P.C., Shah, A.A., Hopkins, C., Graves, B.J. (2007) Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene family. Genes Dev., 21, 1882-1894.
53. Jackson, T.A., Haga, C.L., Ehrhardt, G.R., Davis, R.S., Cooper, M.D. (2010) FcR-like 2 Inhibition of B cell receptor-mediated activation of B cells. J. Immunol., 185, 7405-7412.
54. Thorley-Lawson, D.A. (2001) Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol., 1, 75-82.
55. Dunham, I., Kundaje, A., Aldred, S.F., Collins, P.J., Davis, C.A., Doyle, F., Epstein, C.B., Frietze, S., Harrow, J., Kaul, R. et al. (2012) An integrated encyclopedia of DNA elements in the human genome. Nature, 489, 57-74.
56. Gerstein, M.B., Kundaje, A., Hariharan, M., Landt, S.G., Yan, K.K., Cheng, C., Mu, X.J., Khurana, E., Rozowsky, J., Alexander, R. et al. (2012) Architecture of the human regulatory network derived from ENCODE data. Nature, 489, 91-100.
57. Culhane, A.C., Schwarzl, T., Sultana, R., Picard, K.C., Picard, S.C., Lu, T.H., Franklin, K.R., French, S.J., Papenhausen, G., Correll, M. et al. (2010) GeneSigDB-a curated database of gene expression signatures. Nucleic Acids Res., 38, D716-D725.
58. Liberzon, A., Subramanian, A., Pinchback, R., Thorvaldsdottir, H., Tamayo, P., Mesirov, J.P. (2011) Molecular signatures database (MSigDB) 3.0. Bioinformatics, 27, 1739-1740.
59. Shaffer, A.L., Wright, G., Yang, L., Powell, J., Ngo, V., Lamy, L., Lam, L.T., Davis, R.E., Staudt, L.M. (2006) A library of gene expression signatures to illuminate normal and pathological lymphoid biology. Immunol. Rev., 210, 67-85.
60. Hamoudi, R.A., Appert, A., Ye, H., Ruskone-Fourmestraux, A., Streubel, B., Chott, A., Raderer, M., Gong, L., Wlodarska, I., De Wolf-Peeters, C. et al. (2010) Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism. Leukemia : Off. J. Leukemia Soc. Am., Leukemia Res. Fund, U.K, 24, 1487-1497.
61. Huang, X., Meng, B., Iqbal, J., Ding, B.B., Perry, A.M., Cao, W., Smith, L.M., Bi, C., Jiang, C., Greiner, T.C. et al. (2013) Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP. J. Clin. Oncol., 31, 4520-4528.
62. Barrans, S.L., Crouch, S., Care, M.A., Worrillow, L., Smith, A., Patmore, R., Westhead, D.R., Tooze, R., Roman, E., Jack, A.S. (2012) Whole genome expression profiling based on paraffin embedded tissue can be used to classify diffuse large B-cell lymphoma and predict clinical outcome. British J. Haematol., 159, 441-453.
63. Ngo, V.N., Young, R.M., Schmitz, R., Jhavar, S., Xiao, W., Lim, K.H., Kohlhammer, H., Xu, W., Yang, Y., Zhao, H. et al. (2011) Oncogenically active MYD88 mutations in human lymphoma. Nature, 470, 115-119.
64. Treon, S.P., Xu, L., Yang, G., Zhou, Y., Liu, X., Cao, Y., Sheehy, P., Manning, R.J., Patterson, C.J., Tripsas, C. et al. (2012) MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia. N. Engl. J. Med., 367, 826-833.
65. Lim, K.-H., Barton, G.M., Staudt, L.M. (2013) Oncogenic MYD88 mutants require Toll-like receptors. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research. Cancer Res., 3, Abstract no. 2332.
66. Wang, J.Q., Jeelall, Y.S., Beutler, B., Horikawa, K., Goodnow, C.C. (2014) Consequences of the recurrent MYD88L265P somatic mutation for B cell tolerance. J. Exp. Med., 211, 413-426.
67. Murphy, T.L., Tussiwand, R., Murphy, K.M. (2013) Specificity through cooperation: BATF-IRF interactions control immune-regulatory networks. Nat. Rev. Immunol., 13, 499-509.
68. Shaffer, A.L., Emre, N.C., Lamy, L., Ngo, V.N., Wright, G., Xiao, W., Powell, J., Dave, S., Yu, X., Zhao, H. et al. (2008) IRF4 addiction in multiple myeloma. Nature, 454, 226-231.
69. Ochiai, K., Maienschein-Cline, M., Simonetti, G., Chen, J., Rosenthal, R., Brink, R., Chong, A.S., Klein, U., Dinner, A.R., Singh, H. et al. (2013) Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4. Immunity, 38, 918-929.
70. Jiang, S., Willox, B., Zhou, H., Holthaus, A.M., Wang, A., Shi, T.T., Maruo, S., Kharchenko, P.V., Johannsen, E.C., Kieff, E. et al. (2014) Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A. Proc. Natl. Acad. Sci. U. S. A., 111, 421-426.
71. Portal, D., Zhou, H., Zhao, B., Kharchenko, P.V., Lowry, E., Wong, L., Quackenbush, J., Holloway, D., Jiang, S., Lu, Y. et al. (2013) Epstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2. Proc. Natl. Acad. Sci. U. S. A., 110, 18537-18542.
72. Johansen, L.M., Deppmann, C.D., Erickson, K.D., Coffin, W.F. 3rd, Thornton, T.M., Humphrey, S.E., Martin, J.M., Taparowsky, E.J. (2003) EBNA2 and activated Notch induce expression of BATF. J. Virol., 77, 6029-6040.
73. Senga, T., Iwamoto, T., Humphrey, S.E., Yokota, T., Taparowsky, E.J., Hamaguchi, M. (2002) Stat3-dependent induction of BATF in M1 mouse myeloid leukemia cells. Oncogene, 21, 8186-8191.
74. Li, J., Peet, G.W., Balzarano, D., Li, X., Massa, P., Barton, R.W., Marcu, K.B. (2001) Novel NEMO/IkappaB kinase and NF-kappa B target genes at the pre-B to immature B cell transition. J. Biol. Chem., 276, 18579-18590.
75. Krappmann, D., Wegener, E., Sunami, Y., Esen, M., Thiel, A., Mordmuller, B., Scheidereit, C. (2004) The IkappaB kinase complex and NF-kappaB act as master regulators of lipopolysaccharide-induced gene expression and control subordinate activation of AP-1. Mol. Cell. Biol., 24, 6488-6500.
76. Wang, J., Sun, Q., Morita, Y., Jiang, H., Gross, A., Lechel, A., Hildner, K., Guachalla, L.M., Gompf, A., Hartmann, D. et al. (2012) A differentiation checkpoint limits hematopoietic stem cell self-renewal in response to DNA damage. Cell, 148, 1001-1014.
77. Saito, M., Gao, J., Basso, K., Kitagawa, Y., Smith, P.M., Bhagat, G., Pernis, A., Pasqualucci, L., Dalla-Favera, R. (2007) A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. Cancer Cell, 12, 280-292.
78. Schotte, R., Nagasawa, M., Weijer, K., Spits, H., Blom, B. (2004) The ETS transcription factor Spi-B is required for human plasmacytoid dendritic cell development. J. Exp. Med., 200, 1503-1509.
79. Nagasawa, M., Schmidlin, H., Hazekamp, M.G., Schotte, R., Blom, B. (2008) Development of human plasmacytoid dendritic cells depends on the combined action of the basic helix-loop-helix factor E2-2 and the Ets factor Spi-B. Eur. J. Immunol., 38, 2389-2400.
80. Gilliet, M., Cao, W., Liu, Y.J. (2008) Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol., 8, 594-606.